Fig. 4From: Use of almitrine in spontaneously breathing patients with COVID-19 treated with high-flow nasal cannula oxygen therapy and with persistent hypoxemiaCumulative incidence of intubation during the first week after almitrine administration in responders (red curve, n = 46) and non-responders (blue curve, n = 16) and proportion of patients receiving almitrine at each time point (blue bars)Back to article page